SERIALIZATION, TRENDS AND UPDATES. Lars Olsen Lundbeck, Ottiliavej 9, 2500 Valby, Copenhagen, Denmark Thursday 21 September 2017
|
|
- Eugene Lane
- 6 years ago
- Views:
Transcription
1 SERIALIZATION, TRENDS AND UPDATES Lars Olsen Lundbeck, Ottiliavej 9, 2500 Valby, Copenhagen, Denmark Thursday 21 September 2017
2 Biography Mr. Lars Olsen Global Technology Partner, NNE Dept. Global Best Practise, years experience within Pharmaceutical Packaging Production, Management, Project handling, GMP and Consulting Phone:
3 Safety Features? Old news
4 Serialization Like driving a Car Serialization is the number plate, but you need a lot more in order to drive A car to put the number plate on Insurance Driver instructor Drivers licence Roads & Signs A map to find your way Regulations & Laws Traffic Police Maintenance & Car dealers I.e.: You ll need more than a number plate to drive
5 Stakeholders Healthcare economy I.e. Economical fraud (Taxation/Reimbursement) California (The exempted e-pedigree law) Turkey (Serialization 2009 / Aggregation 2011) Belgium (Sequential stickers) Italy (Bolini stickers) Greece Other countries and states with similar problems where suspicions of fraud are aimed at the pharmacist / distribution and industry Problem to be solved by coding on secondary- and tertiary packaging level with unique marking. Registration, aggregation, Pedigree and supply chain reporting/track & Trace Fake- or substandard products (Counterfeit) General worries regarding population health due to substandard medication I.e. EU/US/Canada/Brazil/Russia/Argentina/China WHO And the rest of the world.. Problems to be solved in the same way as the EU four step approach in the Falsified Medicine Directive. Focus on secure supply chain (GDP/GSP), Internet sales, API/Excipients GMP and Delegated Act on Safety Features. Added with, Fast reaction on batch recall. Currently many individual initiatives. Connecting Pharmaceutical Knowledge ispe.org
6 Stakeholders External Stakeholders (purchasing organizations) Safe medication and usage, patients safety and inventory management I.e. HDA guideline (North American Distribution Association) AMGROS (Purchasing org. hospitals in Denmark) CII (Confederacy of India Industries) Veteran Hospital and Clinics (US) DOD (Department Of Defence, US) The Technical Barcode Committee (Canada) And similar General Purchasing Organisation Registration of treatment and linking medication to individual patients at hospitalization or clinics by intensively use of Automated Identifier on primary- secondary and tertiary pack levels. Unique marking, RFID, QR and similar are in scope Internal Stakeholders (Brand protection) Protect your brands and creating precedence for new industry standards and competitive parameter I.e. Pfizer, Amgen, Biogen, Sanofi, Lilly, AstraZeneca and many more. Securing trustworthiness of a brand so it s easy to do damage control in case of forensic investigations on incidents. Typical done by covert coding but also done with semi-covert and overt options on all packaging levels. There are many different technologies available on the marked (+40) some high cost, low security others low cost, high security. ISO Performance criteria for authentication solutions for anticounterfeiting in the field of material goods, However not yet referenced in pharma- and device legislation. Connecting Pharmaceutical Knowledge ispe.org
7 Summary Global requirements will cover +80% of the pharmaceutical marked by Global requirements are growing fast in complexity and scope Standardisation of formats and data continues but diversity will continue to exist Strategy, Operational and Technology flexibility are needed to fulfil requirements in a timely manner Base Start Local Coding (e.g. NHRN) Step 1 Global Coding (e.g. GTIN) Step 2 GTIN + Batch variable data in 2D Data matrix Step 3 Serial Number for authentication Step 4 Track & Trace / Reporting based on Aggregation Markets start with initial requirement that changes over time Data reporting requirements are often not clear, hence default becomes Unit Level Tracking Pharmaceutical Packaging Performance Excellence are a competitive cost differentiator which are being challenged by Serialization Connecting Pharmaceutical Knowledge ispe.org
8 Summary Overview +80% of marked by 2019 Europe Denmark France Coding 2) European Union 09.FEB.2019 Italy Belgium Greece Turkey 1) Serialization Can wait until 2025 ) Serialization, 2) Serialization, ATD and 3) Aggregation, reporting by law reporting by law, Aggregation by business. Serialization and reporting by law, Aggregation by business.
9 EFPIA Product- and Data-Flow End-to-End With the EFPIA concept Pharma Manufacturer Wholesaler Wholesaler Pharmacist/ Hospital Patient Product Flow Unique Serialization Verification Verification Dispensing 2D Data Matrix on 2 pack 9 Data Transfer Product Serialization Database
10 Summary Overview +80% of marked by Asia China 1) 1) India Domestically distribution Serialization Pakistan 1) Pakistan Australia Serialization. NBA products only Japan Coding. Special products Australia Japan Coding. All products Ramp up Japan Coding. All products Australia Philippines Coding Voluntary Taiwan Track and Trace South Korea 2) Malaysia Pilot Taiwan Coding Taiwan Serialization ) Serialization, 2) Serialization, ATD and 3) Aggregation, reporting by law reporting by law, Aggregation by business. Serialization and reporting by law, Aggregation by business.
11 Summary Overview +80% of marked by 2019 North / South America US Lot Tracking Serialization Grace proposed by FDA ATD by US Pharmacopeia compliance E-Lot Tracking US 27.NOV.2017 Canada Coding. Voluntary Serialization 3) Scope update by positive list Argentina US Serialization 27.NOV.2018 Serialization, Aggregation by business US 27.NOV.2019 Serialization, Aggregation by business US 27.NOV.2020 Canada Adaption of US FDA Guidelines expected 1) US 27.NOV.2023 Brazil Pilot starts Brazil Pilot ends Brazil Pilot concluded 1) Brazil Full rollout Mexico Serialization, Consultation paper 1) Serialization, 2) Serialization, ATD and 3) Aggregation, reporting by law reporting by law, Aggregation by business. Serialization and reporting by law, Aggregation by business.
12 Summary Overview +80% of marked by Middle East Saudi Arabia Serialization 12.MAR.2017 Expected development in 2 3 years 2) Saudi Arabia Coding Coding Coding Oman 31.DEC.2017 UAE 31.DEC.2017 Qatar 31.DEC.2017 Oman Serialization 31.DEC.2018 Expected development in 2 3 years Serialization Serialization UAE Qatar 2) GCC Expected to develop into a new GCC standard, adapted by other Arab markets Coding Jordan 01.JUN.2017 Migration period Coding Jordan 30.JUN.2018 Jordan Start 2020 Serialization Coding Coding Egypt Libya 01.JUN.2017 Coding Serialization Lebanon 01.JUN.2018 Egypt 30.JUN.2018 Egypt 1) 30.JUN ) Serialization, 2) Serialization, ATD and 3) Aggregation, reporting by law reporting by law, Aggregation by business. Serialization and reporting by law, Aggregation by business.
13 Summary Overview +80% of marked by 2019 RoW Ukraine On hold Serialization MoH may align with EU European Union Russia 1) 01.JAN.2017 Voluntary pilot initiated Russia 01.JAN.2018 Product group 1 Russia 01.JAN.2019 Product group 2 Russia 01.JAN.2020 Product group 3 1) Serialization, 2) Serialization, ATD and 3) Aggregation, reporting by law reporting by law, Aggregation by business. Serialization and reporting by law, Aggregation by business.
14 Anti-tampering Device (ATD) General Requirements Purpose of ATD features: Tamper verification features should provide an indication that the outer packaging of a finished product has been opened or tampered with (i.e. indicating a possible adulteration or entry of falsified medicinal products into the legitimate supply chain). Tamper verification features limit the ability to replace the contents of genuine packs. Source: EN 16679:2014 (soon an ISO standard)
15 Folding boxes closed with glue Specially constructed folding boxes Sealing labels and tapes Film wrappers Sleeves Breakable or tear-away closure Display blister pack Flexible packaging Blow-fill-and-seal-container (BFS) New and emerging technologies Categories of ATD features Don t forget Shipper Boxes and Pallets.. USP c1083 and so on
16 Things to consider What needs to be Reported and what has to be Authenticated, and how, where, when? How will Commissioning, Decommissioning and Recommissioning be done and by whom? Know your SKU s and exact market demands in details Know your Supply Caine stakeholders and your Partners business and needs Make a business strategy which goes beyond the Number plate, get it mandated and stick to it, but be prepared to change over time Scope for robustness and justify the upfront CAPEX invest
17 The challenge Number of SKU s increasing OEE decreasing Flexibility decrees High CAPX Increased OPEX Operator / Technician / Support knowledge Extra work routines on all levels Supplier dependences System maintenance Hyper care Rooting ownership in organisation
18 The challenge
19 The challenge Piston rod 99.5% Assembly 96.5% Check weigher 99.5% Assembly 98% Buffer 99.5% Cartoner 98% Label dispenser & Printer 97.5% Cellophane wrap 99% Case packing (manual) 98.5% Labeling 99.5% Radom 99% Syringe 98.5% Stopper 99% Example: 35 meter long syringe packaging line with 13 sub-processes Combined efficiency calculated according to DIN 8743 ~ 83% In reality much lower.. Add extra complexity from Serialization, Anti-tampering Device, Aggregation, Track & Trace, epedigree, China EDMC and many others we ll have a further potential OEE drop of 8 12%
20 Baseline, Relative Production Output (%) Industry Benchmark Data X% T 0 1-5% Δ from T 0 ~ 10% ~ 25% Recovery Phase Return to stable output Start up; Output Reduced Relative to T 0 Low Impact Medium Impact High Impact High Impact Medium Impact Low Impact 0% Line down/set up Relative Duration (Weeks)
21 Technology trends White Line The world first true White Line was introduced by Optima/Eli Lilly in 1994/96 to fulfil Small batch size (15 min. video exist) MediSeal introduced the second line 20 years later White Line concept have been successfully utilized by ALK since mid-90 s on order sizes up to units with proven cost benefit. Also in combination with Bright Stock configurable sales boxes by TT-label and Robot labelling to accommodate many formats Connecting Pharmaceutical Knowledge ispe.org
22 Technology trends Multi Country packs Multi Country packs are a familiar concept in the Pharmaceutical packaging world in order to optimize batch volume Multi-packs are stored in central warehouses and Pick & Pack performed when order enters Modern Serialization will challenge this concept to some degree Example here covers 17 individual markets in one presentation Connecting Pharmaceutical Knowledge ispe.org
23 Technology trends Other on-demand trends BIB/BOB. Original developed by AZ and Harro. Now offered as standard solution for POD. For repack of Bright Stock Print on demand for local small batch execution. Many variances Robot labelling if many formats in small batch sizes Robot packaging and Co-bots for product handling for HSE mitigations and repeatable reliable execution and quality Connecting Pharmaceutical Knowledge ispe.org
24 Trends There are no doubt that Pharmaceutical Packaging are challenged by demands to be more cost effective This is based on markets trends headed by increased competitiveness, smaller batch sizes, costumer centricity, diversity in local legislations (S/N), increase demands for reimbursement favouritism (local production), supply chain lead-times, drug shortage (stock-out mitigations), new drugs and many more Packaging Delivers: 2015 Pharma Packaging Trends 4 Major Trends In Pharmaceutical Packaging 2017 Pharmaceutical Packaging and Labeling 2016 Trend Report #1: Use standard platforms and equipment for all three segments in the same way that large Pharma are using it towards tablet production #2: Design for simplicity and standard equipment (DFM) #3: Do not utilize White line and Print on Demand unless super-small batches (<2.000) and a good business case #4: Combine Flex-Small approach with LSC and Multi Country but watch out for S/N impact #5: Consider your CMO/CPO partners in the scope for in- or outsourcing
25 25
26 Hello World May 2006 I love deadlines. I like the whooshing sound they make as they fly by. 26 Douglas Adams (Hitchhikers Guide to the Galaxy)
Experience with Serialization Implementation as one powerful measure to protect our patients. Françoise Hirth
Experience with Serialization Implementation as one powerful measure to protect our patients Françoise Hirth Objectives 1 2 3 Supply Chain integrity & product security A worldwide concern Pharma Industry
More informationSerialization a global approach. Emanuele Tellaroli Key Account Manager ANTARES VISION
Serialization a global approach Emanuele Tellaroli Key Account Manager ANTARES VISION Beirut 02 June 2016 Serialization concept THE SMALLEST ITEM PUT ON SALE (selling unit) IS IDENTIFIED BY THE COMBINATION
More informationImplementing Unit-level Serialization on a New Packaging Line. Mike Salinas Director of Manufacturing Technology M+W U.S., Inc.
Implementing Unit-level Serialization on a New Packaging Line Mike Salinas Director of Manufacturing Technology M+W U.S., Inc. April 24, 2013 AGENDA The Counterfeit Drug Problem The Potential Market an
More informationGlobal Serialisation Developments and the Need for Convergence. Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015
Global Developments and the Need for Convergence Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015 Developments across the world Regulatory bodies need to address Public Health issues one
More informationDelivering a Comprehensive Serialization Traceability Program GS1 Global Conference 21 Oct 2015 Peggy Staver - Pfizer
Delivering a Comprehensive Serialization Traceability Program GS1 Global Conference 21 Oct 2015 Peggy Staver - Pfizer Overview Pfizer History What it Takes Strategies Organization Solutions Business-as-Usual
More informationCounterfeit Drugs and Supply Chain Security
Counterfeit Drugs and Supply Chain Security Rick Mitzner Senior Director, Engineering Technology Pfizer, Inc. Interphex April 21, 2015 Tragic Consequences Not If But When and Where May 7, 2007 80 children
More informationSupply chain integrity Fighting counterfeiting in healthcare
Supply chain integrity Fighting counterfeiting in healthcare The increasing, global threat of counterfeiting in healthcare What is the problem? Counterfeit drugs may harm the patient. Often impossible
More informationGlobal Track & Trace requirements for better and safer Healthcare
Global Track & Trace requirements for better and safer Healthcare Ulrike Kreysa, VP Healthcare, GS1 Global Office Riyadh, 6 th December 2016 Counterfeiting - The Impact According to Interpol more than
More informationSerialization and epedigree: New Opportunities for Life Sciences Manufacturers
Serialization and epedigree: New Opportunities for Life Sciences Manufacturers Table of Contents Serialization and epedigree: Current Direction... 3 Why Invest in Serialization?... 3 What Tasks do Life
More informationA global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland)
Impressions Kaiseraugst A global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland) SETRM2016 Rastreabilidade de Medicamento Sao Paulo, Jun 2016 Agenda Worldwide,
More informationPharmaceutical Serialization in Brasil. 12 Mar 2015
Pharmaceutical Serialization in Brasil 12 Mar 2015 Agenda Introduction Serialization Supply Chain Overview Global Regulatory Snapshot Discussion and Comparison of RDC No. 54 (Brasil Law) Key Impact Considerations
More informationSerialisation End User View
Serialisation End User View Agenda What is serialisation? Why do we serialise? Regulatory landscape and challenges Approaches to serialisation WHAT IS SERIALISATION? Packaging Levels Lowest saleable unit
More informationImplementation of EU Falsified Medicines Directive
Implementation of EU Falsified Medicines Directive Gerald W Heddell Director, Inspection, Enforcement & Standards Division 26th Annual EuroMeeting 25-27 March 2014 ACV, Vienna Austria Disclaimer The views
More informationVerification of Pharmaceutical Products at the Point of Dispense. Status of the EFPIA Project
Verification of Pharmaceutical Products at the Point of Dispense Speaker : Grant Courtney Status of the EFPIA Project Event: GS1 Global Forum - São Paulo 1 Who is EFPIA? The European Federation of Pharmaceutical
More informationVerification of Pharmaceutical Products at the Point of Dispense. An EFPIA update
Verification of Pharmaceutical Products at the Point of Dispense Speaker : Grant Courtney Event: GS1 Global Conference Location: Washington An EFPIA update 1 Who is EFPIA? The European Federation of Pharmaceutical
More informationThe Past, the Present and the Future that GS1 Healthcare Standards will deliver for the African Continent
The Past, the Present and the Future that GS1 Healthcare Standards will deliver for the African Continent African GS1 Healthcare Conference, Addis Ababa, Ethiopia Tunde Odunlami, CEO GS1 Nigeria 8 May,
More informationHealth Care/Pharmaceutical. GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain
1 Health Care/Pharmaceutical GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain 2 Health Care/Pharmaceutical: GS1 Standards for Serialization and Visibility Within
More informationEuropean Union (EU) Falsified Medicines Directive
European Union (EU) Falsified Medicines Directive Mr. Mike Rose, Vice President, Supply Chain Visibility Johnson & Johnson 18 October 2017 GS1 2017 The Promise of Serialization EU Falsified Medicines Directive
More informationprovides the most effective method of ensuring product security
28 Buenos Aires ETIF 2010 - International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 Supports anti-counterfeiting and public health Combats fraud and prevents reimbursement fraud Reduces
More informationCOUNTERFEIT MEDICINES IMPACT AND POTENTIAL SOLUTIONS
COUNTERFEIT MEDICINES IMPACT AND POTENTIAL SOLUTIONS October 2-3, 2012 The World Bank Innovative technologies to identify fake and substandard drugs in resource-limited settings: Supply chain related technologies
More informationEXISTING TECHNOLOGIES AND TRACK AND TRACE MODELS IN USE AND TO BE DEVELOPED BY MEMBER STATES. TABLE: EXPERIENCES IN COUNTRIES (updated November 2017)
EXISTING TECHNOLOGIES AND TRACK AND TRACE MODELS IN USE AND TO BE DEVELOPED BY MEMBER STATES TABLE: EXPERIENCES IN COUNTRIES (updated November 2017) In November 2017, the Table: Experiences in Countries
More informationBackground to the Falsified Medicines Directive and the Delegated Regulation. Susan Grieve, Principal Pharmacist, Department of Health 12 April 2016
Background to the Falsified Medicines Directive and the Delegated Regulation Susan Grieve, Principal Pharmacist, Department of Health 12 April 2016 Background to the Falsified Medicines Directive and the
More informationGS1 standards for unique identification of medicinal products
GS1 standards for unique identification of medicinal products Lisbon, Portugal 3 July 2013 Silverio Paixão, Chief Innovation & Standards Officier, GS1 Portugal Who is GS1? GS1 a neutral, not-for-profit,
More informationImplementation Reality - Traceability
Implementation Reality - Traceability GS1 Healthcare Global Conference San Francisco, California, USA Wednesday 2 nd October 2013 Agenda Introduction Case Studies Janice Kite, GS1 Global Office Manufacturer
More informationSolutions for Serialization of Pharmaceutical Products. IDT Biologika
Solutions for Serialization of Pharmaceutical Products IDT Biologika October 2017 IDT Biologika IDT Biologika is a specialized CDMO for viral vaccines and biologics. IDT Biologika is a company of the family-owned
More informationChallenges and Opportunities in Pharma: Perspective for an Emerging Middle East April 24th, 2015
Challenges and Opportunities in Pharma: Perspective for an Emerging Middle East 2020 April 24th, 2015 Content Pharma Market Landscape Global Pharma Market Market Categories Middle East Markets Major Challenges
More informationMass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland
Mass Serialization and Traceability Implementation in the Pharma Industry Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland What drives the industry towards more traceability Strategic
More informationSafety Features Required by the Falsified Medicines Directive 2011/62/EU
TOPRA Annual Human Medicines Symposium 2017 Safety Features Required by the Falsified Medicines Directive 2011/62/EU Syed Qadri, Global Regulatory Affairs Strategy EU/ROW Jazz Pharmaceuticals Syed.Qadri@jazzpharma.com
More information3-pin plug & footwear nightmares Dr Peter Stevens Chief Executive
New Zealand 3-pin plug & footwear nightmares Dr Peter Stevens Chief Executive Peter.Stevens@gs1nz.org New Zealand 2009 GS1 New Zealand Pharma - Europe coding & serialisation requirements Cyprus - 2010
More informationCorporate Presentation & Offer for SAP ATTP December 2015
Corporate Presentation & Offer for SAP ATTP December 2015 Page : 1 Page : 2 Content Our Vision Our Company Business Challenges SAP Advanced Track and Trace for Pharmaceuticals (ATTP) Our Offer Our Vision
More informationGS1 Ireland Healthcare User Group (HUG) Information Day
GS1 Ireland Healthcare User Group (HUG) Information Day Overview on EU FMD regulation and unique identification requirements Geraldine Lissalde-Bonnet, GS1 Global Office 28 th March 2017 Overview on EU
More informationA Ten Year Strategic Outlook for the Global Flexible Plastic Packaging Market. Sample pages. Commodity Inside Ltd
A Ten Year Strategic Outlook for the Global Flexible Plastic Packaging Market Sample pages Chapter 1- Executive summary 1.1 Changes in the global flexible plastic packaging industry 1.2 Cost effectiveness
More informationSERIALIZATION. Counterfeit Medicines: A Worldwide Problem
SERIALIZATION Counterfeit Medicines: A Worldwide Problem SERIALIZATION COUNTERFEIT MEDICINES: A WORLDWIDE PROBLEM By Olivier Feraille, Cognex Corporation 10% OF MEDICINES AROUND THE WORLD COULD BE COUNTERFEIT
More informationPfizer s Pedigree & RFID Pilots An Overview
An Overview Granada, February 2008 Tim Marsh Senior Manager Pfizer V-Tag C-Tag Pedigree Pilots Ongoing Work and Collaboration V-Tag Viagra RFID Pilot Mass Serialization at Item, Case and Pallet Level via
More informationWhat To Do or Not To Do? Utility of Medication Traceability to the Patient
What To Do or Not To Do? Utility of Medication Traceability to the Patient Melsen Kwong, Pharm.D. Associate Director Department of Pharmacy Services Cedars-Sinai Medical Center, Los Angeles, CA, USA Objectives
More informationInside EU FMD and the Delegated Acts A Compliance Primer
Inside EU FMD and the Delegated Acts A Compliance Primer TABLE OF CONTENTS 01 02 03 04 05 06 EU FMD And Delegated Acts Requirements How Is EU FMD Governed? What Are The Roles For Different Supply Chain
More informationSE09. Track & Trace Solutions Jeff Bredemus Werner Electric
SE09 Track & Trace Solutions Jeff Bredemus Werner Electric Related Topics SE02 Balluff RFID SE03 Benefits of Image Based Barcode Reading SE08 Vision Solutions for the Food Ind. Solution Area 5 (Motion
More informationFrequently Asked Questions Secondary care services and the Falsified Medicines Directive (FMD)
Medicines are the most common intervention made across the NHS. It is essential that patient can have confidence in the medicines they are supplied and that systems are in place to prevent counterfeit
More informationSummary of Proposed USP General Chapter <1083> Good Distribution Practices Supply Chain Integrity 02/15/2012
Summary of Proposed USP General Chapter Good Distribution Practices Supply Chain Integrity 02/15/2012 This summary was prepared by the Rx-360 Monitoring and Reporting Working Group which tracks
More informationRecommendations on a harmonised implementation of the EU Falsified Medicines Directive using GS1 standards
Executive Summary The EU Falsified Medicines Directive 2011/62/EU (FMD) and the supplementing Commission Delegated Regulation 2016/161 require the interoperability of product verification repositories
More informationThe Danish Generic Medicines Industry Association (IGL)
The Danish Generic Medicines Industry Association (IGL) comments on the concept paper on the delegated act for a unique identifier for medicinal products for human use, and its verification. The Danish
More informationSTRATEGIES FOR DRUG ANTI-COUNTERFEITING IN GLOBAL SUPPLY CHAIN
STRATEGIES FOR DRUG ANTI-COUNTERFEITING IN GLOBAL SUPPLY CHAIN 1 EXECUTIVE SUMMARY Emerging markets are expected to contribute a major share of the growth percentage in global pharma business. Plans have
More informationFuture in Pharmaceuticals. The countdown to Serialisation and the benefits of implementing GS1 Standards
Future in Pharmaceuticals The countdown to Serialisation and the benefits of implementing GS1 Standards GS1 Ireland Healthcare 26 th February 2014 New McKinsey & Company report on benefits of a single
More information4/20/2015. GS1 Healthcare - What barcodes can do for your hospital and your patients
GS1 Healthcare - What barcodes can do for your hospital and your patients Ulrike Kreysa, VP Healthcare GS1 Global Office, Brussels EAHP Congress, Hamburg 26th March 2015 Public Pharmacies for 7 years Hospital
More informationFebruary Seidenader Maschinenbau GmbH Christian Frenz, Product Manager T&T
1 Track&Trace Seidenader Maschinenbau GmbH Why serialization? 3 Why serialization? Some facts on the counterfeit drug market (based on WHO information) Global Drug Market (billion US-$) Total market volume
More informationWhat is Serialisation?
What is Serialisation? An Introduction for the Life Sciences Supply Chain 3 Introduction 4 Part I: Serialisation, Track and Trace, and Market Requirements What is serialisation?....................................................
More informationAgenda. The Past: 1990 s. Healthcare. Supply Efficiencies Pallet Through Retail Packages The Present:
Agenda The Past: 1990 s Supply Efficiencies Pallet Through Retail Packages The Present: 2000-2005 Prevention of Dispensing Errors Unit Dose and Unit of Use Packages The Future: 2005 Forward Counterfeit
More informationGLOBAL VIDEO-ON- DEMAND (VOD)
GLOBAL VIDEO-ON- DEMAND (VOD) HOW WORLDWIDE VIEWING HABITS ARE CHANGING IN THE EVOLVING MEDIA LANDSCAPE MARCH 2016 A CHANGING VIDEO-VIEWING LANDSCAPE Nearly two-thirds of global respondents say they watch
More informationTop 15 Questions and Answers. EU FMD Safety Features and Verification
Top 15 Questions and Answers EU FMD Safety Features and Verification Now set for early 2019, the Delegated Act on safety features for the European Union (EU) Falsified Medicines Directive (FMD) has pharmaceutical
More informationGlobal standards to achieve end-to-end traceability. Robert Ballanger Hospital Aulnay-sous-Bois, France
Global standards to achieve end-to-end traceability Frédérique Fremont Robert Ballanger Hospital Aulnay-sous-Bois, France Topics Background Where we are going Where we are today What this means to you
More informationSerialization Primer
Serialization Primer Introduction Global pharmaceutical distribution networks and supply chains have become more complex and interconnected, quickening the pace of regulations that mandate pharmaceutical
More informationThe European Stakeholder Model A Medicines Verification System for Europe (ESM)
The A Medicines Verification System for Europe (ESM) Fighting g counterfeit medicines to ensure patient safety in Europe Martin Friedrich, i Andreas Walter ESM Stakeholders 2013-07-03 European Medicines
More informationManufacturing Intelligence: Serialization to Improve Processes. Presented By Jean Pierre Allard Serialization Product Manager Optel Vision
Manufacturing Intelligence: Serialization to Improve Processes Presented By Jean Pierre Allard Serialization Product Manager Optel Vision INTRODUCTION Agenda Standards Overview General Solution Architecture
More informationThe Blueprint approach
the way to comply with FMD and its Delegated Regulation: The Blueprint approach Johan Verhaeghe (FMD Project Manager) Frankfurt, 16 February 2016 EGA Vision 2020 To provide sustainable access to high quality
More informationImplementation Reality Traceability
Implementation Reality Traceability How to enable/implement traceability? 2 nd April 2014, Seoul/Korea Round 1 (13:30 15:00) Moderator Grant Courtney, Business Lead, Fingerprint Serialisation, Global Manufacturing
More informationFresh Deciduous Fruit (Apples, Pears, and Grapes): World Markets and Trade
Fresh Deciduous Fruit (Apples, Pears, and Grapes): World Markets and Trade June 9 SUMMARY Global apple production is expected to expand percent and trade is expected to surge 5 percent in 8/9 due to strong
More informationFalsified Medicines Directive: Overview from the Irish Medicines Verification Organisation (IMVO) LEONIE CLARKE - 28 TH MARCH HUG
Falsified Medicines Directive: Overview from the Irish Medicines Verification Organisation (IMVO) LEONIE CLARKE - 28 TH MARCH 2017 - HUG EU requirements * for repositories of unique identifiers Every MS
More informationImplementation of the safety features in medicinal products for human use
Circular published on the INFARMED I.P website in 4 th Sept.2017 Translation of the responsibility of APIFARMA (not official) Information Circular N. º 108/CD/100.20.200 Date: 01/09/1017 Subject: For:
More informationWelcome to our 29 th Global GS1 Healthcare Conference. Follow us on Twitter and tweet about the #GS1HCuae
Welcome to our 29 th Global GS1 Healthcare Conference Follow us on Twitter and tweet about the conference! @GS1Healthcare #GS1HCuae Welcome to the conference 29 th Global GS1 Healthcare Conference Dubai,
More informationHEALTH WEALTH CAREER MERCER LIFE SCIENCES REMUNERATION SURVEY
HEALTH WEALTH CAREER MERCER LIFE SCIENCES REMUNERATION SURVEY MAKE SMART COMPENSATION DECISIONS BY JOINING THE 2016 MERCER TOTAL REMUNERATION SURVEY FOR THE LIFE SCIENCES SECTOR THE LIFE SCIENCES REMUNERATION
More informationMedtec Ireland. Joint Presentation: Role of standards to support post market surveillance. GS1 Ireland 5 th October 2017
Medtec Ireland Joint Presentation: Role of standards to support post market surveillance GS1 Ireland 5 th October 2017 Disclaimer Neither GS1 nor its member organizations nor their staffs have real or
More informationInternational management system: ISO on environmental management
International management system: ISO 14000 on environmental management Introduction In response to the growing interest from businesses in environmental standards, the International Standardization Institute,
More informationExchanging Traceability Data with EPCIS. Senior Manager, Supply Chain Visibility, EPCIS & RFID Bangkok, 31 October 2018 GS1
Exchanging Traceability Data with EPCIS Craig Alan Repec GS1 Healthcare Conference Senior Manager, Supply Chain Visibility, EPCIS & RFID Bangkok, 31 October 2018 GS1 EPCIS: a GS1 Share standard EPCIS CBV
More information2015 MERCER LIFE SCIENCES REMUNERATION SURVEY
2015 MERCER LIFE SCIENCES REMUNERATION SURVEY MAKE SMART COMPENSATION DECISIONS BY JOINING THE 2015 MERCER TOTAL REMUNERATION SURVEY FOR THE LIFE SCIENCES SECTOR THE LIFE SCIENCES REMUNERATION SURVEY PROVIDES
More informationDiscussion paper on recent developments of the Russian system of goods labelling with identification means
Purpose The purpose of this paper is to facilitate the discussions about the establishment of a globally harmonised system for traceability of pharmaceuticals withinrussia, but also between Russia and
More informationMERCER EXECUTIVE REMUNERATION GUIDE THE KEY TO DESIGNING COMPETITIVE EXECUTIVE REMUNERATION IN THE MIDDLE EAST
MERCER EXECUTIVE REMUNERATION GUIDE THE KEY TO DESIGNING COMPETITIVE EXECUTIVE REMUNERATION IN THE MIDDLE EAST CONSIDER THESE QUESTIONS Do you have an easy-to-use source for comparing compensation and
More informationHealth Business Services One Voice for Health Procurement GS1 Healthcare User Group (HUG) Briefing
Health Business Services One Voice for Health Procurement GS1 Healthcare User Group (HUG) Briefing Agenda Introduction Overview Health Business Services Next Steps HBS Strategy for adoption of GS1 Standards
More informationHealthcare Sector. - Upcoming legislations - GS1 standards. Ann Luyckx Healthcare Manager. Phi Data Event 2018
Healthcare Sector - Upcoming legislations - GS1 standards Ann Luyckx Healthcare Manager Phi Data Event 2018 Anti-trust GS1 Belgium & Luxembourg will not enter into any discussion, activity or conduct that
More informationCertification in Central and Eastern Europe
Certification in Central and Eastern Europe Timber Regulation Enforcement Exchange Vienna, 16 September 2015 Dirk Teegelbekkers General Secretary PEFC Germany www.pefc.org www.pefc.org Overview Introduction
More informationSerialisation - the facts
Serialisation - the facts 1 The serialisation challenge The pharmaceutical industry is increasingly falling victim to counterfeit medicines, reimbursement fraud and theft throughout the supply chain. Falsified
More informationDesigning your supply chain as accurately as possible based on thorough product testing
Designing your supply chain as accurately as possible based on thorough product testing Virginie ROUX Sanofi R&D Clinical Supplies Scientific Core Platform Agenda I. Our organization II. Adaptability to
More informationSerialisation Snapshot: The Current State of Readiness
Serialisation Snapshot: The Current State of Readiness Polling Data from NEXUS 17 At NEXUS 17 in Barcelona, nearly 200 people from over 120 companies met to discuss how they re preparing for the challenge
More informationSerialisation. GS1 Standards in Healthcare. Standards Certification Education & Training Publishing Conferences & Exhibits
Serialisation GS1 Standards in Healthcare Standards Certification Education & Training Publishing Conferences & Exhibits Siobhain Duggan Director of Innovation and Healthcare at GS1 Ireland Siobhain is
More informationYour Perfect Match Innovative labels. Smart solutions.
Your Perfect Match Innovative labels. Smart solutions. Solutions Partner for the Pharmaceutical and Medical Device Industry Your Partner for Innovative Label Solutions Welcomes You! 1,000 employees generate
More informationSpirax Sarco. Clean steam overview
Spirax Sarco Clean steam overview Spirax Sarco - investing in solutions for clean systems Clean steam has been an important part of Spirax Sarco s business since pioneering the development of the BT6,
More informationWHITE PAPER. Solutions to Global Pharmaceutical Supply Chain Challenges
WHITE PAPER Solutions to Global Pharmaceutical Supply Chain Challenges Solutions to Global Pharmaceutical Supply Chain Challenges Find out how a contract packaging company can deliver the expertise and
More informationOTS. FEEL GOODS. COMPANY PROFILE
OTS. FEEL GOODS. COMPANY PROFILE CONTENTS 4 ABOUT US 6 TRANSPORT 8 MISSION 10 VISION 12 SERVICES 14 SALES AND CUSTOMER SERVICE 16 IMPORT / EXPORT AND CROSSTRADE 18 LOGISTICS 20 CUSTOMS 22 PROJECT DIVISION
More informationInternational Business Environment & Strategy
International Business Environment & Strategy Drivers of isation June 2010 Slides based on Yip, G. (1995):- Johnson, Scholes & Whittington (2005) Exploring Corporate Strategy, 7 th edition Robert Jones
More informationInternational and ANVISA Traceability Requirements
International and ANVISA Traceability Requirements 1 Buenos Aires ETIF 2010 - International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 1. Supply Chain Issues 2. COUNTERFEITING 3. Worldwide
More informationImplementation of the safety features in medicinal products for human use
Translation of the responsibility of APIFARMA (not official) Information Circular N.º XXX/CD/cód. class. Date: DD/MM/YYYY Subject: For: Implementation of the safety features in medicinal products for human
More informationMHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents
MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Enforcement activities - Impact of the falsified medicines directive Presented by: Peter Blundell, GDP Inspector Impact of the falsified
More informationImplementing Serialization
Implementing Serialization - HowtodoitRight Harpal Singh, Director - Business Development, ACG- Inspection harpal.singh@acg-world.com Contents What - Track and Trace- Global Regulation Roadmap and GS1
More informationBeing Prepared for Track and Trace: DSCSA 101
Being Prepared for Track and Trace: DSCSA 101 Susanne Somerville, Founder The LinkLab Eric Garvin, Founder, The LinkLab Brian Daleiden, VP Industry Marketing and Co-Founder, TraceLink Objective of Today
More informationENABLING TRUSTED TRADE TROUGH SECURE TRACK AND TRACE
ENABLING TRUSTED TRADE TROUGH SECURE TRACK AND TRACE Tom Doyle Chief Commercial Officer May 2014 AGENDA I. What is the evolution of Track and Trace? II. What are the drivers for Secure Track and Trace?
More informationWhat Is Next After the Results of Implementing GS1 Pilot in the Public Health Supply Chains!
What Is Next After the Results of Implementing GS1 Pilot in the Public Health Supply Chains! ongoing progress in Pakistan Dr. Muhammad Tariq, Country Director, Pakistan Field Office USAID Global Health
More informationImpacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario
Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Innovacion en Packaging Primario 1 Contents Company Highlight What s Changing in Pharma Pharma Trends Harmonisation New Requirements
More informationOVERVIEW OF DRUG REGISTRATION REQUIREMENTS FOR PHARMACEUTICALS IN EMERGING MARKET
Badjatya et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), 227-232 227 Available online at http://jddtonline.info REVIEW ARTICLE OVERVIEW OF DRUG REGISTRATION REQUIREMENTS FOR PHARMACEUTICALS
More informationGood Manufacturing Practices. Single Points of Contact. Surveillance and Monitoring. Good Distribution Practices. Track and Trace System
Single Points of Contact Good Manufacturing Practices Surveillance and Monitoring Good Distribution Practices 10 1 9 Track and Trace System 2 8 3 7 Good Import/ Export Practices 4 6 5 Internet Sales Clinical
More informationPRODUCT INFORMATION. DWS Pallet MEASURING AND WEIGHING PALLETS AND OTHER BULKY FREIGHT ITEMS. Track and trace systems
PRODUCT INFORMATION DWS Pallet MEASURING AND WEIGHING PALLETS AND OTHER BULKY FREIGHT ITEMS Track and trace systems 2 DWS Pallet TRACK AND TRACE SYSTEMS SICK 8018446/2015-11-19 PRECISION THAT PAYS OFF
More informationMultiple Sclerosis Treatment Market Research Report - Global Forecast till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/940 Multiple Sclerosis Treatment Market Research Report - Global Forecast till 2023 Report / Search Code: MRFR/HC/0434-HCRR
More informationJerome Lepeintre. Delegation of the European Union to China and Mongolia
Jerome Lepeintre Delegation of the European Union to China and Mongolia EU Falsified Medicine Directive Jerome Lepeintre, Minister Counsellor for Health and, Delegation of the European Union to China and
More informationEU IDMP Taskforce Falsified Medicines Directive and European Medicines Verification System Update
EU IDMP Taskforce Falsified Medicines Directive and European Medicines Verification System Update 19 th February 2016 EMA London Falsified Medicines February 9 th 2016 Delegated Regulation (EU) 2016/161
More informationCancer survival trends and inequalities: what is the role for Europe?
Cancer survival trends and inequalities: what is the role for Europe? European Joint Action on Comprehensive Cancer Control 2014-2017 Brussels, Belgium, 13 May 2015 Measures of cancer burden definition
More informationFalsified Medicines Directive (FMD) Leyla Hannbeck MRPharmS, MBA, MSc, MA NPA Chief Pharmacist and Director of Pharmacy
Falsified Medicines Directive (FMD) Leyla Hannbeck MRPharmS, MBA, MSc, MA NPA Chief Pharmacist and Director of Pharmacy Falsified medicines: the facts Falsified medicines may: Be fraudulently mislabelled
More informationResponse to: PUBLIC CONSULTATION IN PREPARATION OF A LEGAL PROPOSAL TO COMBAT COUNTERFEIT MEDICINES FOR HUMAN USE
Response to: PUBLIC CONSULTATION IN PREPARATION OF A LEGAL PROPOSAL TO COMBAT COUNTERFEIT MEDICINES FOR HUMAN USE EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE GENERAL CONSUMER GOODS, PHARMACEUTICALS
More informationThe new European Regulations the Importance of GS1 standards in the Healthcare sector
The new European Regulations the Importance of GS1 standards in the Healthcare sector Safer, more efficient care starts with a simple scan Ulrike Kreysa, Senior Vice-President Healthcare, GS1 Global Office
More informationPharmaceutical Packaging
Pharmaceutical Packaging 2017 2021 Section I: Introduction A. Pharmaceuticals defined B. Pharmaceutical packaging defined C. Study organization D. Methodology E. Geographic regions F. Conventions Section
More informationDAVA. Drugs Authentication and Verification Application. A portal for Indian Drugs authentication, track and trace
DAVA Drugs Authentication and Verification Application A portal for Indian Drugs authentication, track and trace Avinash Pedgaonkar 15-12-2015 Objectives To ensure the genuineness and authenticity of the
More informationGlobal management and control system of automatic doors for BRT systems (Bus Rapid Transit)
Global management and control of automatic doors for BRT s (Bus Rapid Transit) What is it? How does it work? What does it consist of? It is an integrated of automatic doors for BRT stations that synchronises
More informationUpdate Version 1.0 Based on the information available at that date of NCA.
Update 05.2017 Version 1.0 Based on the information available at that date of NCA. 1 Check if your company is affected: check the scope of the Falsified Medicines Directive (FMD) = Download general presentation
More information